Mechanical Engineer

We are looking for a skilled and experienced Mechanical Engineer to develop engineering solutions for research and commercial development across our platforms, and to liaise with partners across the globe to

Share
C++ Software Developer

We are looking for a C++ Software Developer who, as a key member of the development team, will lead and shape the software architecture for the next generation of QuantuMDx

Share
Staff Spotlight: Sam Bhatt

Sam Bhatt is a Programme Manager at QuantuMDx. Here, Sam tells us more about himself and gives us an insight into his role. When did you start working at QuantuMDx? 

Share
QuantuMDx attains CE-IVD marking for SARS-CoV-2 Test

QuantuMDx Group today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within the European Union. QuantuMDx has now registered the

Share
Software Test Engineer

QuantuMDx is looking for a skilled and motivated Software Test Engineer to test software for both our Q-POC™ platform and internal research platforms, in addition to liaising with our engineering and

Share
QuantuMDx launches rapid, sensitive SARS-CoV-2 test

QuantuMDx Group today announces the launch of its sensitive SARS-CoV-2 assay for laboratory use, which delivers a result in approximately 70 minutes. Working with British manufacturing partner Biofortuna Limited, QuantuMDx

Share
QuantuMDx: Leadership changes and business update

QuantuMDx today announces a business update and the appointments of Jonathan O’Halloran as Chief Executive Officer and Neil Butler as Chairman of the Board, as the company begins its transition

Share
Staff Spotlight: Isbelis Lopez

Isbelis Lopez is a KTP Associate at QuantuMDx. Here, she tells us more about her role. When did you know you wanted to be a scientist and why?   Growing up

Share
QuantuMDx and Ontera collaborate to advance sepsis diagnosis

Improving outcomes for sepsis patients and promoting antibiotic stewardship QuantuMDx and Ontera, have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection. The

Share
FIND collaborates with QuantuMDx and SpeeDx

Investigating feasibility of rapid, low-cost STI diagnostics development QuantuMDx and SpeeDx today announced a collaboration with the Foundation for Innovative New Diagnostics (FIND). The global non-profit organization drives development and

Share